WO2026095847 - OIL-BASED VITAMIN B12 SUSPENSION FOR ORAL ADMINISTRATION ACROSS VARIOUS AGE GROUPS
National phase entry is expected:
Publication Number
WO/2026/095847
Publication Date
07.05.2026
International Application No.
PCT/SE2025/010014
International Filing Date
22.10.2025
Title **
[English]
OIL-BASED VITAMIN B12 SUSPENSION FOR ORAL ADMINISTRATION ACROSS VARIOUS AGE GROUPS
[French]
SUSPENSION À BASE D'HUILE DE VITAMINE B12 POUR ADMINISTRATION ORALE À DIFFÉRENTS GROUPES D'ÂGE
Applicants **
MEDSYD AB
Inventors
VIBERG, Cedric
PERSSON, Peter
Priority Data
2430549-2
01.11.2024
SE
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
SPRO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 1880 | |
| EPO | Filing, Examination, Granting | 9194 | |
| Japan | Filing, Examination, Granting | 1924 | |
| South Korea | Filing, Examination, Granting | 1593 | |
| USA | Filing, Examination, Granting | 4740 |

Total:
19,331
Contact Us
Abstract[English]
The invention relates to an oil-based suspension of vitamin B12 formulated for oral administration, primarily intended for infants but also suitable for children, adults, and elderly individuals. The suspension comprises vitamin B12 uniformly distributed within a vegetable oil matrix and is free from additives, stabilizers, and emulsifiers, including lecithin.[French]
L'invention concerne une suspension à base d'huile de vitamine B12 formulée pour administration orale, principalement destinée aux nourrissons mais également appropriée pour les enfants, les adultes et les personnes âgées. La suspension comprend de la vitamine B12 uniformément distribuée dans une matrice d'huile végétale et est exempte d'additifs, de stabilisants et d'émulsifiants, y compris la lécithine.